ENTRY       D10838            Mixture   Drug
NAME        Abacavir, lamivudine and zidovudine;
            Trizivir (TN)
PRODUCT     TRIZIVIR (ViiV Healthcare Company)
  GENERIC   ABACAVIR, LAMIVUDINE AND ZIDOVUDINE (Lupin Pharmaceuticals)
COMPONENT   (Abacavir sulfate [DR:D00891] | Abacavir [DR:D07057] | Abacavir succinate [DR:D02734]), Lamivudine [DR:D00353], Zidovudine [DR:D00413]
CLASS       Antiviral
             DG03107  Anti-HIV agent
REMARK      ATC code: J05AR04
            Product: D10838<US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR04 Zidovudine, lamivudine and abacavir
                  D10838  Abacavir, lamivudine and zidovudine &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Abacavir Sulfate/ Lamivudine/ Zidovudine
                D10838  Abacavir, lamivudine and zidovudine
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D10838  Abacavir, lamivudine and zidovudine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D10838  Abacavir, lamivudine and zidovudine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D10838  Abacavir, lamivudine and zidovudine &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10838
DBLINKS     PubChem: 319902638
///
